Background: Breast cancer is common cancer among females in rural India and is rapidly catching up to cervical cancer in rural India. Metastasis can occur after the initiation of treatment or at the time of diagnosis. The stage at initial presentation and underlying biology of the tumor has an impact on prognosis and metastasis of the tumor. The objective of the study was to study the correlation between tumor size and lung metastasis and to find the correlation between ER, PR status, and lung metastasis.Methods: This study was conducted in 82 patients with breast carcinoma coming to the department of the general surgery and oncology at Government Stanley Medical College and Hospital. Details of cases and full history obtained. Routine blood investigations were done. Tumor size is evaluated by clinical examination and imaging. For all patients, core needle biopsy is done to confirm the diagnosis and receptor status. IHC status of the tumor is obtained from the pathologist. Presence of lung metastasis documented by CECT chest.Results: In this study, the prevalence rate of lung metastasis in carcinoma breast patients is 9.75% Total number of Carcinoma Breast are 82, in which lung metastasis is seen in 8 cases and CECT chest is normal in 74 patients. The prevalence rate of lung metastasis in ER-positive patients is 9.90%. The prevalence rate of lung metastasis in ER-negative patients is 10.81%. The prevalence rate of metastasis in PR positive patients is 9.52%. The prevalence rate of metastasis in PR negative patients is 10%. Of 34 cases with HER-2 positive status 3 patients presented with lung metastasis with a prevalence rate of 8.82%. Of 48 cases with HER-2 negative status 5 cases presented with lung metastasis with a prevalence rate of 10.42%.Conclusions: In this study prevalence of lung metastasis in carcinoma breast is 9.75%. There seems to be no correlation between ER, PR and HER-2 neu status and lung metastasis. There is also no correlation between clinically T2 and T3 tumors and lung metastasis. Whereas clinically T4 tumors seem to have a higher incidence of lung metastasis.
Subphrenic abscess though a common presentation itself encountered in surgical practice due to various cause, a tubercular subphrenic abscess in the absence of coexisting tuberculous abdomen presenting as a complication of pulmonary tuberculosis is extremely rare. Only a very few cases have been reported as an extrapulmonary manifestation of tuberculosis so far. We report a case of isolated sub-diaphragmatic abscess which responded well with anti-tuberculous therapy despite all other interventions.
Schwannoma also referred to as neurilemmoma or neurinomas arise from the Schwann cells of the autonomic nerves, peripheral nerves and cranial nerves except optic and olfactory nerves. Head and neck schwannomas account for 25 to 45% of schwannomas and the most common being vagal schwannomas and cervical sympathetic chain schwannomas. Schwannomas arising from the trigeminal nerve are rare and this case report consists of a schwannoma presenting as a left preauricular swelling involving the region of parotid extending from foramen ovale through the infratemporal fossa up to the parapharyngeal space. A combined preauricular trans mandibular approach enabled a complete excision of the tumor. Histopathological confirmation of a benign schwannoma was obtained and the patient is feeling well with minimal postoperative facial palsy with no trismus, occlusion abnormalities and no signs of recurrence on follow up.
Obturator hernia is a rare pelvic hernia with an incidence of 1%. It is the protrusion of abdominal content through the obturator foramen. Here we report a rare case of obturator hernia in thin, emaciated female patient of age 60 years with complication of ileal transection, hence emphasizing early presentation and diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.